Delivery Order SPE2DB24D9144-SPE2DB25FCMYS

DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $17,851.68 firm fixed-price delivery order by the Defense Logistics Agency on August 25, 2025, for Mirena 52 mg systems with an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation and represents part of DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The company serves as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and medical supplies to Department of Defense healthcare facilities.

The Mirena system is a hormonal intrauterine device used for contraception and treatment of heavy menstrual bleeding, and this delivery order will be fulfilled at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group's extensive federal contract portfolio with the DLA demonstrates its capability to supply a diverse range of pharmaceutical products, from specialty medications and biologics to over-the-counter items and medical devices, supporting military health facilities nationwide. The company's consistent success in securing federal contracts without set-aside designations reflects its competitive position as a woman-owned small business in the federal pharmaceutical procurement market.